Posted in | News | Laser | Medical Optics

Erchonia’s Zerona Laser Receives FDA Market Clearance

Editorial Checklist

Reviewed

Sep 10 2010

The U.S. Food and Drug Administration (FDA) has granted market clearance to Erchonia’s Zerona, a non-invasive body contouring laser device.

Zerona

The Zerona becomes the first non-invasive laser device to get the FDA market clearance in the United States. The device has been proven to be both safe and effective for reducing thighs, hips and waist.

A randomized, placebo-controlled clinical trial was conducted to evaluate 67 study participants. The study results showed that an average loss of 3.65” was observed across patients’ thighs, hips and waist over a two-week period.

The Zerona laser produces a cold energy, which does not create any thermal effect on the tissue. The laser targets fat cells and causes them to disintegrate, thereby reducing the body volume considerably. The fat is removed from the patient’s body via a natural fat removal process. The Zenora laser treatment eliminates downtime and does not cause any side effects.

Source:

http://www.erchonia.com

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback

Public Comment

Private Feedback to AZoOptics.com

Submit

X Series Compact Raman Spectrometer

X Series Compact Raman Spectrometer

Discover the X Series compact Raman spectrometer for superior performance within a compact design.

From Wasatch Photonics, Inc.

Femtosecond Fiber Laser : VINCI-1064

Femtosecond Fiber Laser : VINCI-1064

The VINCI series of ultrafast fiber lasers has a central emission wavelength of 1064 nm and features a unique combination of short pulse durations.

From TeraXion Inc.

Advanced F-Theta Lenses for Precision Imaging Systems

Advanced F-Theta Lenses for Precision Imaging Systems

These F-theta lenses by Avantier are designed for consistent spot size and uniform field curvature correction, ideal for high-resolution imaging applications.

From Avantier Inc.

Hi, I'm Azthena, you can trust me to find commercial scientific answers from AZoNetwork.com.

To start a conversation, please log into your AZoProfile account first, or create a new account.

Registered members can chat with Azthena, request quotations, download pdf's, brochures and subscribe to our related newsletter content.

A few things you need to know before we start. Please read and accept to continue.

Use of “Azthena” is subject to the terms and conditions of use as set out by OpenAI.
Content provided on any AZoNetwork sites are subject to the site Terms & Conditions and Privacy Policy.
Large Language Models can make mistakes. Consider checking important information.

I understand, and agree to receive occasional emails about Azthena such as usage tips and new feature announcements.

Please check the box above to proceed.

Great. Ask your question.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.